Robert Lisicki
Robert Lisicki brings over 25 years of experience in the pharma/biotech sector, most recently Robert was CEO and Board Members at InCarda Therapeutics. Prior to that he was the Chief Commercial Officer of Arena Pharmaceuticals, where he provided global visionary leadership for the $6.7 billion growth-stage biopharmaceutical company through their acquisition by Pfizer in March […]
Glynn Wilson
Dr. Glynn Wilson is the Chairman & Head of R&D at Jupiter Wellness, Inc.. Dr. Wilson brings an extensive background of success in corporate management and product development with tenures in both multinational and start-up biotech organizations. He was formerly Head of Drug Delivery at SmithKline Beecham Pharmaceuticals, Research Area Head in Advanced Drug Delivery […]
John R. Murphy
Mr. Murphy serves on our Board of Directors and Chairman of our Audit Committee. Since 2003, John R. Murphy has served on the Board of Directors of O’Reilly Automotive, Inc. (NASDAQ: ORLY), where he served as Chairman of the Audit Committee from 2003 until 2019. Currently, he serves as the Chairman of the Human Capital […]
Steven Zelenkofske, DO
Dr. Zelenkofske has served on the Board of Directors of Dinaqor AG since May 2020. He has served as Chief Medical Officer of SwanBio Therapeutics since June 1, 2020. Dr. Zelenkofske is also an advisor to Veralox Therapeutics, Inc., as Chair of the Scientific Advisory Board, a position he has held since March 2020. Previously, […]
Quang Pham
Quang Pham has served as our Chief Executive Officer since he formed the Company. He previously served as Chairman & CEO of Espero BioPharma, Inc., a company he also founded and the previous sponsor of the tecarfarin IND. He then served as a consultant to HESP LLC, the assignee for Espero to Horizon Technology Finance. […]
